Clinical Trial: PCS6422G1-01

Trial Status: Open
Disease Types: Esophageal/Gastric, Colorectal
Trial ID PCS6422G1-01
Sponsor ID Processa

A Phase 1b Dose-Escalation Study of the Safety and Pharmacokinetics of Fixed-Dose PCS6422 with Escalating Doses of Capecitabine Administered Orally to Patients with Advanced, Refractory Gastrointestinal Tract Tumors


Learn More About This Trial

Other Relevant Trials
Trial ID 20341

BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer (20-041-NCP)

Principal Investigator
Keeran R. Sampat, MD
3 Locations
Trial ID GO-010
Sponsor ID Gritstone

A Phase 2/3, Randomized, Open-Label Study of Maintenance GRT-C901/GRT-R902, A Neoantigen Vaccine, in Combination with Immune Checkpoint Blockade for Patients with Metastatic Colorectal Cancer

1 Location